Flibanserin: Restoring Female Sexual Desire and Satisfaction
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 12 | $3.44 | $41.28 (0%) | 🛒 Add to cart |
| 24 | $3.26 | $82.56 $78.26 (5%) | 🛒 Add to cart |
| 36 | $3.01 | $123.84 $108.36 (13%) | 🛒 Add to cart |
| 60 | $2.92 | $206.40 $175.44 (15%) | 🛒 Add to cart |
| 88 | $2.58
Best per pill | $302.72 $227.04 (25%) | 🛒 Add to cart |
Synonyms | |||
Flibanserin, commonly referred to as “female Viagra,” is a non-hormonal, centrally-acting prescription medication approved for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Unlike medications that address physiological aspects of sexual function, flibanserin works on neurotransmitter systems in the brain to help restore balance and increase spontaneous sexual desire. It represents a significant advancement in addressing a complex and often distressing condition, offering a targeted approach to improving sexual health and overall quality of life for eligible patients. Treatment requires careful medical supervision and a thorough understanding of its mechanism, benefits, and risks.
Features
- Active ingredient: Flibanserin 100 mg
- Pharmacological class: Multifunctional serotonin receptor agonist and antagonist
- Administration: Oral tablet, taken once daily at bedtime
- Prescription status: Schedule IV controlled substance, requires healthcare provider prescription
- Mechanism of action: Modulates neurotransmitters (serotonin, dopamine, norepinephrine) in brain circuits governing sexual desire
- FDA-approved indication: Treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD)
Benefits
- Increases the frequency of satisfying sexual events by acting on central nervous system pathways
- Enhances spontaneous sexual desire and reduces associated distress
- Non-hormonal mechanism avoids systemic hormonal side effects
- Improves overall sexual satisfaction and intimacy in relationships
- Addresses the neurochemical imbalance associated with HSDD
- Contributes to improved emotional well-being and quality of life
Common use
Flibanserin is specifically indicated for premenopausal women diagnosed with acquired, generalized hypoactive sexual desire disorder (HSDD). HSDD is characterized by a persistent deficiency or absence of sexual fantasies and desire for sexual activity, causing marked distress or interpersonal difficulty, which is not better accounted for by another medical condition, substance use, or severe relationship distress. The “acquired” specifier indicates that the low desire developed in a patient who previously had no problems with sexual interest, while “generalized” means it occurs regardless of the type of sexual activity, situation, or partner. It is not intended for use in postmenopausal women or men, and it is not indicated for sexual dysfunction due to co-existing medical or psychiatric conditions, or relationship factors. Diagnosis should be made using validated diagnostic tools and a thorough clinical assessment by a qualified healthcare provider.
Dosage and direction
The recommended dosage is 100 mg taken orally once daily at bedtime. Taking the medication at bedtime is crucial to minimize the risk of hypotension (low blood pressure), syncope (fainting), and central nervous system depression (e.g., sedation, sleepiness), as these adverse reactions are most common shortly after ingestion. The tablet should be swallowed whole and can be taken with or without food; however, consistent administration relative to meals is advised. Patients should not consume alcohol at any time during treatment with flibanserin, due to a significant risk of severe hypotension and syncope. Dose escalation is not recommended, and the 100 mg dose should not be exceeded. Efficacy should be re-evaluated after 8 weeks of treatment to determine if continuing therapy is warranted. Discontinuation should be considered if no meaningful improvement in desire and associated distress is observed.
Precautions
Flibanserin carries several important precautions. It can cause severe hypotension and syncope, particularly with concomitant alcohol use. A certified risk evaluation and mitigation strategy (REMS) program is in place to ensure prescribers and pharmacists are educated on this risk and that patients are counseled accordingly. It also causes central nervous system depression (e.g., somnolence, sedation); patients should exercise caution when engaging in activities requiring full alertness, such as driving or operating machinery, until they know how the drug affects them. Hepatic impairment significantly increases flibanserin exposure; it is contraindicated in patients with hepatic impairment and its use with moderate or strong CYP3A4 inhibitors is also contraindicated. Blood pressure should be monitored in patients taking concomitant medications that can lower blood pressure. Women of childbearing potential should use effective contraception during treatment.
Contraindications
Flibanserin is contraindicated in the following scenarios:
- Concomitant use with alcohol
- Concomitant use with moderate or strong CYP3A4 inhibitors (e.g., ketoconazole, fluconazole, erythromycin, verapamil, diltiazem, grapefruit juice)
- Patients with hepatic impairment
- Concomitant use with other CNS depressants (strong contraindication due to additive effects)
- Postmenopausal women or men
- A history of hypersensitivity to flibanserin or any component of the formulation
Possible side effects
The most common adverse reactions (≥2% incidence and greater than placebo) are:
- Dizziness
- Somnolence (sleepiness)
- Nausea
- Fatigue
- Insomnia
- Dry mouth
- Other reported side effects can include:
- Hypotension (low blood pressure)
- Syncope (fainting)
- Anxiety
- Abdominal pain
- Constipation
- Rash
- Paresthesia (tingling sensation) The risk of syncope and hypotension is significantly increased by alcohol consumption. Patients should be aware of these potential effects and report any severe or persistent symptoms to their healthcare provider.
Drug interaction
Flibanserin is primarily metabolized by the cytochrome P450 3A4 (CYP3A4) enzyme system and is a weak CYP2C19 inhibitor and CYP3A4 inducer. Significant interactions include:
- Alcohol: Contraindicated. Concomitant use can lead to severe hypotension, syncope, and CNS depression.
- Strong/Moderate CYP3A4 Inhibitors: Contraindicated (e.g., ketoconazole, itraconazole, voriconazole, clarithromycin, diltiazem, verapamil, grapefruit juice). These agents dramatically increase flibanserin plasma concentrations.
- CYP3A4 Inducers (e.g., rifampin, carbamazepine, St. John’s Wort): May decrease flibanserin exposure, potentially reducing efficacy.
- Other CNS Depressants (e.g., benzodiazepines, opioids, sleep aids, antipsychotics): Additive sedative effects; use with extreme caution.
- Medications that Lower Blood Pressure: Additive hypotensive effects; monitor blood pressure.
- CYP2C19 Substrates (e.g., omeprazole, diazepam): Flibanserin may increase their exposure.
Missed dose
If a dose is missed at the scheduled bedtime, the patient should skip that dose and take the next dose at the usual time the following bedtime. The dose should not be doubled to make up for a missed dose, as this increases the risk of adverse effects such as hypotension and syncope. Maintaining the strict once-daily at bedtime schedule is important for both safety and consistent therapeutic effect.
Overdose
In case of suspected overdose, which may manifest as severe dizziness, profound sedation, syncope, or hypotension, immediate medical attention must be sought. There is no specific antidote for flibanserin overdose. Management is supportive and should include continuous monitoring of vital signs (especially blood pressure and heart rate) and ECG. Symptomatic treatment for hypotension (e.g., intravenous fluids, vasopressors) and CNS depression may be necessary. Due to the risk of syncope, the patient should be kept in a supine position with legs elevated. Gastric lavage or administration of activated charcoal may be considered if ingestion was very recent.
Storage
Store flibanserin tablets at room temperature, between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). Keep the medication in its original container, tightly closed, to protect it from light and moisture. Always keep all medications out of the reach of children and pets. Do not flush unused medication down the toilet or pour it into a drain. Dispose of any unused or expired medication through a medicine take-back program or according to FDA guidelines.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here. The use of flibanserin must be managed by a qualified healthcare professional who can assess your individual health status, confirm a diagnosis of HSDD, and determine if this treatment is appropriate for you given its risks and contraindications.
Reviews
Clinical studies and patient-reported outcomes indicate a nuanced profile:
- Clinical Trial Data: In randomized, placebo-controlled trials, women taking flibanserin 100 mg daily reported a statistically significant increase in the number of satisfying sexual events (SSE) and a decrease in distress related to low sexual desire compared to placebo, though the absolute increase in SSE was modest (approximately 0.5 to 1 more event per month on average).
- Patient Testimonials (Compiled Themes): Many women report a meaningful improvement in spontaneous desire and a reduction in the anxiety and distress associated with HSDD, describing it as “freeing” and “relationship-saving.” A common sentiment is that the effect is subtle but significant over time. However, a substantial number of users discontinue due to side effects, primarily dizziness, fatigue, and nausea, noting that the side effects sometimes outweigh the benefits. The strict alcohol prohibition is frequently cited as a significant lifestyle limitation.
- Expert Consensus: Prescribers emphasize that flibanserin is not a “female Viagra” in the sense of an on-demand drug; it is a chronic-use medication that requires patience and careful management. It is considered a valuable option for a specific subset of motivated patients with pure HSDD who understand the risks, particularly those for whom the distress of HSDD significantly impacts their quality of life and who can strictly adhere to the dosing and alcohol restrictions.